Bicycle Therapeutics Ltd (BCYC) — Financial Flexibility Index
Bicycle Therapeutics Ltd (BCYC) has a Financial Flexibility Index of -0.48x as of September 2025. Free cash flow of $-70.50 Million (operating CF $-71.17 Million minus capex $674.00K) represents 0% of total liabilities ($145.47 Million). Check cash flow reinvestment rate of Bicycle Therapeutics Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bicycle Therapeutics Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Bicycle Therapeutics Ltd across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Bicycle Therapeutics Ltd.
Annual Financial Flexibility Index for Bicycle Therapeutics Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Bicycle Therapeutics Ltd. Explore cash flow to debt ratio of Bicycle Therapeutics Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.00x | $-163.49 Million | $-164.72 Million | $163.81 Million | ▼ -288.2% |
| 2023 | -0.26x | $-57.70 Million | $-60.63 Million | $224.41 Million | ▲ +46.4% |
| 2022 | -0.48x | $-67.12 Million | $-86.11 Million | $139.83 Million | ▼ -402.2% |
| 2021 | -0.10x | $-12.76 Million | $-14.79 Million | $133.54 Million | ▲ +62.1% |
| 2020 | -0.25x | $-16.59 Million | $-17.79 Million | $65.69 Million | ▲ +84.1% |
| 2019 | -1.59x | $-27.06 Million | $-28.61 Million | $17.00 Million | ▼ -868.6% |
| 2018 | -0.16x | $-24.89 Million | $-26.08 Million | $151.45 Million | ▼ -6495.2% |
| 2017 | 0.00x | $-302.00K | $-1.42 Million | $121.19 Million | ▲ +99.9% |
| 2016 | -2.89x | $-11.02 Million | $-11.27 Million | $3.81 Million | — |